Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 1/2015

01-01-2015 | 2014 SSAT Plenary Presentation

Predictors and Outcomes of Readmission for Clostridium difficile in a National Sample of Medicare Beneficiaries

Authors: Courtney E. Collins, M. Didem Ayturk, Fred A. Anderson Jr., Heena P. Santry

Published in: Journal of Gastrointestinal Surgery | Issue 1/2015

Login to get access

Abstract

Background

Rates of Clostridium difficile (CD) infections are increasing. Elderly patients may be at particular risk of recurrent CD infection. Little is known about the risk for CD readmission specifically in this age group.

Methods

A 5 % random sample of Medicare data (2009–2011) was queried for patients surviving a hospitalization for CD by ICD-9 code. Demographic (age, sex, gender), clinical (Elixhauser index, gastrointestinal comorbidities), and hospitalization (length of stay, ICU admission) characteristics as well as exposure to antibiotics and interim non-CD hospitalization were compared for those with and without a readmission for CD. A multivariable survival analysis was used to determine predictors of readmission.

Results

Of 7,564 patients surviving a CD hospitalization, 8.5 % were readmitted with CD in a median of 25 days (interquartile range (IQR) 14–57). In multivariable survival analyses, interim non-CD hospital exposure was the strongest predictor of CD readmission (hazard ration (HR) 3.75 95 %, confidence interval (CI) 3.2–4.42). Oral and intravenous/intramuscular (IV/IM) antibiotic use, Elixhauser index, and CD as the primary diagnosis also increased the risk of CD readmission. Discharge to hospice, long-term care or a skilled nursing facility decreased the odds of CD readmission.

Conclusion

Hospital exposure and antibiotic use put elderly patients at risk of CD readmission. Exposure to these factors should be minimized in the immediate post discharge period.
Literature
2.
go back to reference Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne. 2004;171 (5):466–72. doi: 10.1503/cmaj.1041104.CrossRef Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne. 2004;171 (5):466–72. doi: 10.1503/cmaj.1041104.CrossRef
3.
go back to reference Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005;40(11):1591–7. doi:10.1086/430315.CrossRef Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005;40(11):1591–7. doi:10.​1086/​430315.CrossRef
6.
go back to reference Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert review of gastroenterology & hepatology. 2010;4(4):409–16. doi:10.1586/egh.10.48.CrossRef Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert review of gastroenterology & hepatology. 2010;4(4):409–16. doi:10.​1586/​egh.​10.​48.CrossRef
7.
11.
go back to reference Eyre DW, Walker AS, Wyllie D, Dingle KE, Griffiths D, Finney J, et al. Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;55 Suppl 2:S77–87. doi:10.1093/cid/cis356.CrossRef Eyre DW, Walker AS, Wyllie D, Dingle KE, Griffiths D, Finney J, et al. Predictors of first recurrence of Clostridium difficile infection: implications for initial management. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;55 Suppl 2:S77–87. doi:10.​1093/​cid/​cis356.CrossRef
12.
go back to reference Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Medical care. 1998;36(1):8-27.PubMedCrossRef Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Medical care. 1998;36(1):8-27.PubMedCrossRef
13.
go back to reference Elixhauser A, Steiner C, Gould C. Readmissions following Hospitalizations with Clostridium difficile Infections, 2009: Statistical Brief #145. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD) 2006. Elixhauser A, Steiner C, Gould C. Readmissions following Hospitalizations with Clostridium difficile Infections, 2009: Statistical Brief #145. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD) 2006.
14.
go back to reference McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW, Greenberg RN. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America. 1999;20(1):43–50. doi:10.1086/501553.CrossRef McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW, Greenberg RN. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America. 1999;20(1):43–50. doi:10.​1086/​501553.CrossRef
15.
go back to reference Khanna SPD. Clostridium difficile infection; management and strategies for a difficult disease. Therapeutic Advances in Gastroenterology. 2014;7: 72-86. doi:10.1177/1756283X13508519.PubMedCentralPubMedCrossRef Khanna SPD. Clostridium difficile infection; management and strategies for a difficult disease. Therapeutic Advances in Gastroenterology. 2014;7: 72-86. doi:10.1177/1756283X13508519.PubMedCentralPubMedCrossRef
18.
go back to reference Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. The Journal of hospital infection. 2008;70(2):142–7. doi:10.1016/j.jhin.2008.06.026.PubMedCrossRef Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. The Journal of hospital infection. 2008;70(2):142–7. doi:10.​1016/​j.​jhin.​2008.​06.​026.PubMedCrossRef
19.
go back to reference Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2012; 18 Suppl 6:21–7. doi:10.1111/1469-0691.12046.CrossRef Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2012; 18 Suppl 6:21–7. doi:10.​1111/​1469-0691.​12046.CrossRef
21.
go back to reference Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. 2004;171(1):51–8.CrossRef Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. 2004;171(1):51–8.CrossRef
22.
go back to reference Louie TJ, Miller MA, Crook DW, Lentnek A, Bernard L, High KP, et al. Effect of age on treatment outcomes in Clostridium difficile infection. Journal of the American Geriatrics Society. 2013;61(2):222–30. doi:10.1111/jgs.12090.PubMedCrossRef Louie TJ, Miller MA, Crook DW, Lentnek A, Bernard L, High KP, et al. Effect of age on treatment outcomes in Clostridium difficile infection. Journal of the American Geriatrics Society. 2013;61(2):222–30. doi:10.​1111/​jgs.​12090.PubMedCrossRef
24.
go back to reference Owens RC. Clostridium difficile-associated disease: changing epidemiology and implications for management. Drugs. 2007; 67(4):487–502.PubMedCrossRef Owens RC. Clostridium difficile-associated disease: changing epidemiology and implications for management. Drugs. 2007; 67(4):487–502.PubMedCrossRef
25.
go back to reference Kincaid SE. Clostridium difficile-associated disease: impact of the updated SHEA/IDSA guidelines. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists. 2010;25(12):834–6. doi:10.4140/TCP.n.2010.834.CrossRef Kincaid SE. Clostridium difficile-associated disease: impact of the updated SHEA/IDSA guidelines. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists. 2010;25(12):834–6. doi:10.​4140/​TCP.​n.​2010.​834.CrossRef
26.
go back to reference Lucado J, Gould C, Elixhauser A. Clostridium Difficile Infections (CDI) in Hospital Stays, 2009: Statistical Brief #124. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD)2006. Lucado J, Gould C, Elixhauser A. Clostridium Difficile Infections (CDI) in Hospital Stays, 2009: Statistical Brief #124. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD)2006.
27.
go back to reference Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonisation and disease. Lancet. 1990;336(8707):97–100.PubMedCrossRef Johnson S, Clabots CR, Linn FV, Olson MM, Peterson LR, Gerding DN. Nosocomial Clostridium difficile colonisation and disease. Lancet. 1990;336(8707):97–100.PubMedCrossRef
28.
go back to reference Borrego F, Gleckman R. Principles of antibiotic prescribing in the elderly. Drugs & aging. 1997;11(1):7–18.CrossRef Borrego F, Gleckman R. Principles of antibiotic prescribing in the elderly. Drugs & aging. 1997;11(1):7–18.CrossRef
29.
go back to reference Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. 2008;179(8):767–72. doi:10.1503/cmaj.071812.CrossRef Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. 2008;179(8):767–72. doi:10.​1503/​cmaj.​071812.CrossRef
31.
go back to reference Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Annals of internal medicine. 1984;100(2):258-68.PubMedCrossRef Eraker SA, Kirscht JP, Becker MH. Understanding and improving patient compliance. Annals of internal medicine. 1984;100(2):258-68.PubMedCrossRef
32.
go back to reference Commission MPA. A Data Book: Medicare Part D Program. Washington2010 March 2010. Commission MPA. A Data Book: Medicare Part D Program. Washington2010 March 2010.
Metadata
Title
Predictors and Outcomes of Readmission for Clostridium difficile in a National Sample of Medicare Beneficiaries
Authors
Courtney E. Collins
M. Didem Ayturk
Fred A. Anderson Jr.
Heena P. Santry
Publication date
01-01-2015
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 1/2015
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-014-2638-6

Other articles of this Issue 1/2015

Journal of Gastrointestinal Surgery 1/2015 Go to the issue